Drug & Medical Distributors
5 companies across the library’s three pools, one row each. The columns are the line items this kind of business is read on; each header names its basis, and the margins and returns are medians over each company’s readable record — the through-cycle level, never one year’s print. Rows open largest first by latest-year revenue, and every column sorts both ways — the re-ordering is the reader’s own act, and a sorted view keeps its order in the address bar. The company stays in view as the columns scroll. A dash is a figure that could not be read; n/a is one that does not apply to that member; both sit at the back of a sorted column.
From the latest filings · data as of July 9, 2026.
As a group: median revenue $222.6B; median gross margin 5.0%; median operating margin 1.1%; median owner earnings $1.9B; median return on invested capital 14.6%; 1 of 5 hold net cash. Medians of this table’s own columns, over the members each applies to · data as of July 9, 2026.
| latest fiscal year, USD | median over the record | median over the record | op. cash − maintenance capex · latest FY, USD | after tax · median over the record | debt − cash & ST investments · latest FY, USD | ||||
|---|---|---|---|---|---|---|---|---|---|
| MCK | McKesson Corporation | Drug & Medical Distributors | $403.4B | 5.0% | 1.1% | $5.9B | — | $3.1B | |
| COR | Cencora Inc. | Drug & Medical Distributors | $321.3B | 3.0% | 0.8% | $3.2B | 37.8% | $3.3B | |
| CAH | Cardinal Health Inc. | Drug & Medical Distributors | $222.6B | 4.2% | 0.4% | $1.9B | 13.6% | $4.5B | |
| HSIC | Henry Schein Inc. | Drug & Medical Distributors | $13.2B | 30.9% | 5.9% | $573M | 12.6% | $2.2B | |
| NUS | Nu Skin | Drug & Medical Distributors | $1.5B | 74.5% | 8.7% | $46M | 15.6% | +$16M cash |
Every figure is recomputed from the company’s own SEC or EDINET filings, the same way as on its page; the columns name facts, weigh nothing, and form no rank.